Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Integrative genome-wide expression profiling identifies three distinct molecular subgroups of renal cell carcinoma with different patient outcome.

BMC cancer - 23 Jul 2012

Beleut Manfred, Zimmermann Philip, Baudis Michael, Bruni Nicole, Bühlmann Peter, Laule Oliver, Luu Van-Duc, Gruissem Wilhelm, Schraml Peter, Moch Holger

Abstract excerpt

BACKGROUND: Renal cell carcinoma (RCC) is characterized by a number of diverse molecular aberrations that differ among individuals. Recent approaches to molecularly classify RCC were based on clinical, pathological as well as on single molecular parameters. As a consequence, gene expression patterns reflecting the sum of genetic aberrations in individual tumors may not have been recognized. In an attempt to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Renal Cell
Share to Cell Line, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cluster Analysis

Share to DNA Copy Number Variations

Share to Gene Expression Profiling

Share to Kidney Neoplasms

Share to Prognosis

Share to Proportional Hazards Models

Source

Open in PubMed Open full text

Identifiers

PMID: 22824167
DOI: 10.1186/1471-2407-12-310
PMCID: PMC3488567

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Integrative genome-wide expression profiling identifies three distinct molecular subgroups of renal cell carcinoma with different patient outcome.PMID 22824167Read ↗

Genome-wide screening of copy number alterations and LOH events in renal cell carcinomas and integration with gene expression profile.Semantic proximity Read ↗

Genomics of Renal Cell Cancer: The Biology Behind and the Therapy AheadSemantic proximity Read ↗

Integrated Phenotypic/Genotypic Analysis of Papillary Renal Cell Carcinoma Subtypes: Identification of Prognostic Markers, Cancer-related Pathways, and Implications for Therapy.Semantic proximity Read ↗

Genomic Analysis as the First Step toward Personalized Treatment in Renal Cell CarcinomaSemantic proximity Read ↗

Subgroup-Independent Mapping of Renal Cell Carcinoma—Machine Learning Reveals Prognostic Mitochondrial Gene Signature Beyond Histopathologic BoundariesSemantic proximity Read ↗

Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma.Semantic proximity Read ↗

Multilevel Genomics-Based Taxonomy of Renal Cell Carcinoma.Semantic proximity Read ↗

A novel molecular signature identifies mixed subtypes in renal cell carcinoma with poor prognosis and independent response to immunotherapySemantic proximity Read ↗

An algorithm for classifying tumors based on genomic aberrations and selecting representative tumor models.Semantic proximity Read ↗

Toward Biological Subtyping of Papillary Renal Cell Carcinoma With Clinical Implications Through Histologic, Immunohistochemical, and Molecular Analysis.Semantic proximity Read ↗

Gene Signatures of Progression and Metastasis in Renal Cell CancerSemantic proximity Read ↗

Single-cell gene programs define subtype identity and metastatic trajectories in renal cell carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.